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Abstract
Objective—To analyze organization-level correlates of immunization coverage among
adolescents served by high-volume primary care providers in North Carolina.
Method—We randomly selected 91 clinics with at least 200 active records for patients ages 11–
18 in the North Carolina Immunization Registry. For the 105,121 adolescents served by these
clinics, we obtained immunization status for 6 vaccines, including human papillomavirus (HPV)
vaccine (females only); meningococcal conjugate; and tetanus, diphtheria, and pertussis booster
(Tdap).
Results—Clinics specializing in pediatrics had higher coverage for meningococcal vaccine (OR
= 1.79, 95% CI: 1.25–2.55), Tdap vaccine (OR = 1.22, 95% CI: 1.00–1.50), and childhood
vaccines. However, pediatric clinics had lower coverage for HPV vaccine initiation (OR = 0.70,
95% CI: 0.52–0.94). Other correlates, which varied by vaccine, included policies related to
vaccine documentation and the age at which clinics recommended vaccines.
Conclusion—Overall, adolescents were more likely to receive vaccines, except HPV vaccine, if
they attended a pediatric clinic with supportive clinical policies.
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Vaccinating adolescents can reduce morbidity and mortality associated with several
infectious diseases. In the United States, guidelines currently recommend administering
three vaccines to children ages 11 to 12, with catch-up vaccination throughout adolescence:
human papillomavirus (HPV) vaccine; meningococcal conjugate; and tetanus, diphtheria,
and pertussis booster (Tdap) [1]. Despite this recommendation, uptake of adolescent
vaccines remains uneven. In 2011, initiation of the three-dose HPV vaccine series was 53%
for girls ages 13 to 17, and series completion was 35% [2]; initiation and completion for
boys was much lower, 4% and < 1% [3]. In the same year, uptake of meningococcal vaccine
(for boys and girls) was 71% and uptake of Tdap vaccine was 78% [2]. Improving
adolescent vaccination rates even further, particularly for HPV vaccine, is important for
achieving population-level protection against vaccine-preventable diseases.
While characteristics of individuals or families, such as income, race, and ethnicity, are
associated with uptake of adolescent vaccines, characteristics of healthcare organizations are
also important [2,4–6]. For example, clinics with specialties such as pediatrics may be better
equipped to stock and administer adolescent vaccines given their focus on younger patients
[7–9]. Previous research has demonstrated that vaccine coverage also varies based on
characteristics such as clinic size [10], the racial composition of clinics’ patient populations
[8], and clinics’ participation in publicly-funded immunization programs [8,11].
Similarly, vaccination may be supported by organizational practices and policies [6,12]. For
example, clinics that send immunizations reminders to patients (or their parents) achieve a 5
to 20 percent increase in vaccination coverage [13]. Having clinic-based systems in place to
document vaccination is also associated with increased odds of adolescent vaccination
[6,14,15]. Research is needed to better understand the relative importance of these
organizational factors, particularly with regard to how the influence of these factors varies, if
at all, by vaccine type [6].
We sought to assess the association of clinic characteristics with adolescents’ immunization
status by analyzing data on vaccine provision in North Carolina clinics. To further probe the
importance of provider practices and policies, we also examined how these factors
correlated with adolescents’ immunization status. By investigating organizational-level
correlates of immunization, this study aims to inform healthcare quality improvement efforts
to raise vaccine coverage levels among adolescents.
Methods
Participants and Sampling
Using the North Carolina Immunization Registry, we randomly selected 91 primary care
clinics that were high-volume adolescent vaccine providers, defined as having active records
for at least 200 adolescent patients. We then randomly selected a subset of 61 of these
clinics to survey about their practices and policies related to vaccination of adolescents
(response rate: 100%). Inclusion criteria for this study included participation in the North
Carolina Immunization Program, which includes Vaccines for Children (VFC), a federally-
funded program that provides free vaccines to children ages 18 and under who are
uninsured, under23 insured, Medicaid-insured, or American Indian/Alaska Native. Around
94% of the approximately 1,300 public and private clinics that participate in the North
Carolina Immunization Program use the Immunization Registry [16], which contains
information on 54% of the population of adolescents in the state [17].
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Vaccination coverage—The North Carolina Immunization Registry (NCIR) provided
data on adolescents’ immunization status for the full sample of 91 clinics. We gathered data
on the numbers of patients in each clinic who had received: one and three doses of human
papillomavirus (HPV) (female patients only); meningococcal conjugate; and tetanus,
diphtheria, and pertussis booster (Tdap). We also assessed coverage with childhood
vaccines: two doses of measles, mumps, and rubella (MMR); three doses of hepatitis B
(HepB); and two doses of varicella.
Clinic characteristics—The Registry also provided data for all 91 clinics on the
following organizational characteristics: clinic size, measured as thousands of active
adolescent patients (log transformed in analyses); clinic specialty (pediatrics, family
medicine, or other); ratio of female to male adolescent patients; and racial/ethnic
composition of patient population. We also assessed VFC-participation via a count of
instances in which patients qualified for the program because of insurance status or
American Indian/Alaska Native ethnicity (log transformed in analyses).
Immunization practices and policies—One author (AD), who coordinates state-wide
efforts to increase adolescent vaccination, invited each clinic’s vaccine coordinator to
complete a web-based survey on immunization practices and policies: use of a reminder/
recall system; review of patients’ immunization records at each visit; and policies about the
age at which clinics recommend each adolescent vaccine (a continuous variable). The survey
also assessed the timeliness of vaccination documentation in NCIR (document vaccination
during the healthcare visit; at the end of the visit; at the close of business on the day of the
visit; or at least every two weeks) and the number of computers available for documentation
in the Immunization Registry (one computer per clinic with access to NCIR or more than
one computer per clinic).
Data Analysis
We examined characteristics of clinics and their patients using descriptive statistics. To
better understand why some immunization records had incomplete data for patient
demographics (sex, race, and ethnicity), we correlated clinics’ rates of incompleteness with
clinic characteristics and policies.
We analyzed clinic-level correlates of vaccination coverage separately for each vaccine.
Using the full sample of 91 clinics, we assessed associations between immunization status
and clinic characteristics using bivariate logistic regression that adjusted for clustering at the
clinic level and weighted vaccination for the number of patients in the clinic. We entered
statistically significant correlates into a multivariate logistic regression model, again
accounting for clinic level clustering and weighting. For the subset of 61 clinics reporting on
immunization practices and policies, we again used bivariate and then multivariate logistic
regression to evaluate the association with vaccination. We report odds ratios from bivariate
analyses in tables, and odds ratios from multivariate analyses in text. For vaccines that had
only one statistically-significant bivariate correlate, the additional multivariate logistic
regression was unnecessary.
We conducted a sensitivity analysis by examining correlates of immunization status for the
adolescents in the target age range for adolescent vaccines (ages 11–12) and compared the
results to those for the full sample (ages 11–18). Because of the lack of variability reported
with regard to the practice of performing chart reviews to determine if patients need any
immunizations (97% reported doing this at each visit), analyses did not include this variable.
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We used Stata Version 12.0 (Statacorp, College Station, TX), and all tests were two-tailed
with a critical alpha of .05.
Results
Characteristics of Patients and Clinics
Most adolescent patients were white (47.0%) or African-American (25.0%), and 4.9% were
Hispanic (Table 1). Adolescent patients were evenly split between males and females.
Clinics had an average of 632 instances in which patients qualified for the VFC program. On
average, clinics had 4,745 patients with immunization registry records (almost all would
have been children), of whom 1,155 were adolescents ages 11 to 18 (Table 2). Clinic
specialties were pediatrics (58%), family medicine (41%), and internal medicine (1%). In
analyses, we combined family medicine and internal medicine clinics. There were no
differences between pediatric and family medicine clinics on their characteristics or policies,
except that on average, pediatric clinics were larger (number of adolescent patients: family
medicine, mean = 580, pediatrics, mean = 1,567, p < .001).
Most clinics reported not using a reminder/recall system (69%), although having more than
one computer with access to NCIR throughout the clinic was the norm (90%) (Table 2).
Most clinics had a policy of recommending Tdap and HPV vaccines at 10 years of age or
younger, which is earlier than the target age of 11 to 12 years specified by national
guidelines (62% and 53%, respectively). The majority of clinics (84%) had a policy of
recommending meningococcal conjugate to patients ages 11–12 years old, in accordance
with national guidelines.
Clinics with higher rates of incomplete data for sex, race, and ethnicity had fewer patients
initiating VFC services and recommended adolescents receive Tdap vaccine at a younger
age (all p < .05), though there was no association for the other vaccination age policies for
HPV and meningitis vaccines. Clinics with higher rates of incomplete data for race and
ethnicity had larger patient populations (both p < .05). Other correlates did not show any
consistent pattern.
Adolescent Vaccines
HPV vaccine—HPV vaccine initiation and completion rates among adolescent females
were 47.8% and 27.6%, respectively (Table 2). In multivariate analysis of clinic
characteristics, HPV vaccine initiation was higher in clinics with a higher female-to-male
adolescent patient ratio (odds ratio [OR] = 1.96, 95% confidence interval [CI]: 1.01–3.80) or
with a higher proportion of African-American patients (OR = 2.13, 95% CI: 1.02–4.47). In
addition, bivariate analyses found that uptake was higher in family medicine than in
pediatric clinics (Table 3) (family medicine clinics: 54.9% coverage, pediatric clinics:
45.9% coverage; Table S1). For the analysis of immunization policies, multivariate analysis
found that only age at which practitioners began recommending Tdap vaccine was
associated with HPV vaccine initiation, such that the odds of receiving the first dose of HPV
vaccine were higher as the age providers began recommending Tdap increased (OR = 1.40,
95% CI: 1.19–1.65). In bivariate analysis, HPV vaccine initiation was also associated with
the time to documentation in NCIR (Table 4).
HPV vaccine series completion showed a similar pattern to series initiation. For clinic
characteristics, higher female-to-male ratios were associated with higher completion (Table
3). For immunization policies, completion was associated with older ages of Tdap
recommendation (OR = 1.22, 95% CI: 1.03–1.44), and time to documentation in NCIR was
significant in bivariate but not multivariate analysis (Table 4).
Moss et al. Page 4













Meningococcal vaccine—The meningococcal conjugate vaccination rate was 60.5%.
Uptake of meningococcal vaccine was higher for adolescents attending a pediatric versus a
family medicine clinic (family medicine clinics: 49.3% coverage, pediatric clinics: 63.5%
coverage; Table S1). In multivariate analysis of immunization policies, uptake was
positively associated with having more than one computer with access to NCIR per clinic
(OR = 3.42, 95% CI: 1.59–7.38) and negatively associated with older ages of meningococcal
conjugate recommendation (OR = 0.80, 95% CI: 0.69–0.93). Additionally, bivariate analysis
found that uptake of meningococcal conjugate was associated with time to documentation in
NCIR (Table 4).
Tdap—The Tdap vaccination rate was 78.9%. Tdap vaccination was higher for adolescents
attending a pediatric versus a family medicine clinic (family medicine clinics: 76.1%
coverage, pediatric clinics: 79.6% coverage; Table S1). In addition, multivariate analysis
found that uptake of Tdap was negatively associated with older ages of meningococcal
conjugate recommendation (OR = 0.92, 95% CI: 0.88–0.97). Bivariate analysis found that
Tdap vaccination was also positively related to having more than 1 computer per clinic
(Table 4).
Childhood Vaccines
Hepatitis B—The hepatitis B vaccination rate (3 doses) was 81.1%. In multivariate
analysis of hepatitis B vaccine, uptake was positively associated with adolescent patient load
(OR = 1.38, 95% CI: 1.07–1.76). In bivariate analysis, uptake was negatively associated
with proportion of Hispanic patients and positively associated with VFC-participation.
Uptake was also higher in pediatric clinics than in family medicine clinics (Table 3) (family
medicine clinics: 68.9% coverage, pediatric clinics: 84.3%; Table S1). Hepatitis B
vaccination was lower in clinics that took longer to document vaccinations in NCIR (Table
4).
MMR—The MMR vaccination rate (2 doses) was 77.8%. In multivariate analysis, MMR
uptake was higher for clinics with more adolescent patients (OR = 1.58, 95% CI: 1.22–2.04).
In bivariate analysis of clinic characteristics, MMR vaccination was negatively associated
with female-to-male patient ratio and proportion of Hispanic patients. MMR vaccination
was positively associated with VFC-participation, and uptake was higher in pediatric clinics
than in family medicine clinics (family medicine clinics: 63.7% coverage, pediatric clinics:
81.5%; Table S1). Uptake of MMR vaccine was lower in clinics that took longer to
document vaccinations in NCIR (Table 4).
Varicella—The varicella vaccination rate (2 doses) was 54.0%. In multivariate analysis,
uptake was higher in clinics with higher female-to-male patient ratios (OR = 0.33, 95% CI:
0.11- 0.99), with more adolescent patients (OR = 1.44, 95% CI: 1.19–1.75), and for pediatric
clinics compared to family medicine clinics (OR = 1.52, 95% CI: 1.01–2.28) (family
medicine clinics: 35.2% coverage, pediatric clinics: 59.0% coverage, Table S1). In addition,
varicella vaccine uptake was lower in clinics that used reminder/recall systems (OR = 0.59,
95% CI: 0.37–0.94) (clinics without reminder/recall systems: 57.0% coverage, clinics with
reminder/recall systems: 45.0%, Table S1) and lower in clinics that took longer to document
vaccinations in NCIR (compared to documentation during a visit: at the close of business,
OR = 0.38, 95% CI: 0.24– 0.61).
Sensitivity Analysis
Bivariate results for adolescents ages 11–12 were similar to those reported for the full
sample, except that the percent of African-American patients was positively correlated with
vaccination status for each of the childhood vaccines (hepatitis B: OR = 4.67, 95% CI: 1.98–
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11.03, p < .001; MMR: OR = 2.70, 95% CI: 1.02–7.13, p < .05; varicella: OR = 2.03, 95%
CI: 0.94–4.38, p = .07).
Discussion
Clinic-level correlates of vaccination differed for adolescent and childhood vaccines in our
sample of 91 North Carolina clinics that served more than 100,000 adolescents. Uptake of
two adolescent vaccines, meningococcal conjugate and Tdap, was higher in pediatric clinics
and correlated negatively with older age of meningococcal vaccine recommendation. In
contrast, uptake of HPV vaccine was higher in family medicine clinics and correlated
positively with age at which clinics begin recommending Tdap. Coverage for childhood
vaccines (i.e., hepatitis B; MMR; and varicella vaccines) was higher for clinics with more
adolescent patients, those specializing in pediatrics rather than family medicine, and those
with policies for more timely documentation of vaccine administration in the North Carolina
Immunization Registry.
Clinic specialty was a consistent correlate of vaccination for both childhood and adolescent
vaccines. Adolescents were more likely to have received vaccines if they attended pediatric
clinics than family medicine clinics, but the relationship reversed for HPV vaccine. In
general, pediatric clinics may be better equipped to administer childhood and adolescent
vaccines given that they exclusively serve these populations. For example, pediatricians may
be more accustomed to and knowledgeable about administering catch-up doses of childhood
vaccines than are family practice clinicians [18–20]. Why HPV vaccine might pose an
exception to this general trend is unclear, but our findings corroborate previous work
showing higher HPV vaccine initiation and completion in family practice versus pediatric
clinics [21]. However, two studies [7,8] reported the opposite finding (i.e., rates of HPV
vaccination were higher in pediatric clinics than in family medicine clinics). Given that
attitudinal research suggests pediatricians are more supportive of HPV vaccination than
other specialties [22], additional research is needed to investigate barriers to HPV
vaccination that may be disproportionately impacting pediatricians.
Consistent correlates of childhood vaccination rates, but not adolescent vaccination rates,
were higher adolescent patient load and more prompt documentation in NCIR. Larger clinics
may have better infrastructure supporting routine administration and electronic
recordkeeping. More prompt documentation of vaccination (i.e., during the healthcare visit
versus at the end of the visit, at the close of business, or at least every two weeks) would
support administration of childhood vaccines by enabling record review during each
healthcare encounter and possibly leading to increased record completeness.
Policies for age of adolescent vaccination seemed to affect vaccination rates differently. The
age at which providers began recommending Tdap and meningococcal vaccines had no
relationship with uptake of childhood vaccines but strongly correlated with the uptake of
adolescent vaccines. Policies for later administration of meningococcal conjugate were
associated with lower odds of vaccination for both that vaccine and Tdap, which is not
surprising given that such a policy gives providers less time and, possibly, fewer
opportunities to vaccinate patients before age 18. In contrast, HPV vaccination was
positively correlated with later recommendation of Tdap. Although routine administration of
Tdap is recommended for adolescents ages 11 to 12 years, many of the clinics in this study
reported recommending the vaccine before the target age, with some clinics recommending
Tdap to children as young as 7 years. Providers who recommend Tdap early likely miss
opportunities to concomitantly recommend and provide HPV vaccine. Alternatively, if they
do recommend HPV vaccine, parents or children may refuse it given that young age is a
common reason for not getting HPV vaccine [23]. Whatever the case, these findings suggest
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that Tdap and meningococcal vaccination benefit from policies for younger vaccination, but
such policies are a detriment to HPV vaccination. This conflict emphasizes the need for
clinic policies that balance the benefits of early and concomitant vaccination, such as the
CDC recommendation that practitioners begin administering these vaccines to children at
age 11.
Strengths of this study include a large sample size and the assessment of vaccination status
using the North Carolina Immunization Registry. Data from electronic databases have
shown equivalent or superior results when compared to self-reported data [24,25]. However,
some electronic records are likely to reflect recordkeeping rather than actual practices (e.g.,
doses not recorded), particularly for childhood vaccines that could have been administered
years before clinics started using the Registry. Due to the cross-sectional nature of this
study, causal inference is not possible. In addition, the clinic-level nature of the data
precluded the possibility of investigating personal attributes (e.g., individual race); instead,
our analysis focused on the understudied area of clinic composition (e.g., proportion of
patients of particular races). Another limitation was missing data on sex, race, and ethnicity
for some portion of patients in clinics.
Conclusion
Increasing coverage of catch-up and recommended vaccines during adolescence could
reduce morbidity and mortality from vaccine-preventable diseases [1]. National surveys
have demonstrated that most vaccination rates are still below the Healthy People 2020
objectives [26], and better understanding of how characteristics of clinics and their
populations relate to vaccine uptake may help address these low rates. This investigation of
patterns of vaccination among adolescents attending large clinics in North Carolina suggests
the importance of clinic specialty, documentation practices, and age recommendations for
vaccine administration. Future research and interventions should explore how to maximize
adolescent immunization by changing clinic policies around vaccines for this population.
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• For most vaccines, pediatric clinics had higher coverage than family practices.
• However, HPV vaccination was lower in pediatric clinics.
• Vaccination coverage correlated with supportive clinical policies.
• Vaccination was higher in clinics with more frequent documentation.
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Table 1
Characteristics of adolescents, ages 11–18.
n %
Sex
  Male 50,177 47.7%
  Female 49,230 46.8%
  Unknown 5,714 5.4%
Race
  White 51,883 47.0%
  Unknown 28,165 25.5%
  African American or Black 27,551 25.0%
  Asian 1,301 1.2%
  Other 904 0.8%
  American Indian/Alaska Native 405 0.4%
  Native Hawaiian/Pacific Islander 102 0.1%
Ethnicity
  Non-Hispanic 65,190 59.1%
  Unknown 39,758 36.0%
  Hispanic 5,363 4.9%
Insurance type
  Patients who initiated VFC-eligibility, mean (SD) 632 (67)
Note. The total number of individuals varies due to measurement at two different time points, approximately three months apart.
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Table 2
Clinic characteristics and policies.
Characteristics (k = 91)
Clinic specialty
  Family medicinea 42%
  Pediatrics 58%
Clinic size
  All patients, mean (SD) 4,745 (419)
  Adolescent patients, mean (SD) 1,155 (128)
Policies (k = 61)
General procedures
  Use a reminder/recall system 31%
  Review patient's chart for vaccines at each visit 97%
When practitioners document vaccination administration in NCIR
  During the visit 67%
  At the end of the visit 12%
  At the close of business 18%
  At least every two weeks 3%
Computers per clinic
  1 computer 10%
  > 1 computer 90%
Age to start recommending vaccine
  Tdap
    <11 years 62%
    11–12 years 38%
    >12 years 0%
Meningococcal conjugate
    <11 years 10%
    11–12 years 84%
    >12 years 7%
HPV vaccine
    <11 years 53%
    11–12 years 44%
    >12 years 3%
a
includes 1 internal medicine clinic.
Note. NCIR = North Carolina Immunization Registry; Tdap = tetanus, diphtheria, and pertussis booster; HPV = human papillomavirus.
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